fig3
Figure 3. Optimal assessment method for different HCC treatments at different disease stages. HCC: Hepatocellular carcinoma; LI-RADS: liver imaging reporting and data system; mRECIST: modified RECIST; EASL: European Association for the Study of the Liver; OS: overall survival; TTR: time to recurrence; QoL: quality of life.
